Plenary Speakers Explore Advances Toward Precision Medicine for Immuno-Oncology at AACR Annual Meeting

A panel of four researchers discussed the latest advances in immuno-oncology, including developments in the understanding of immunotherapy modalities, efficacy, and combination strategies during the plenary session Precision Medicine for Immuno-Oncology and the Promise for the Future on Tuesday, April 12, during the American Association for Cancer Research (AACR) Annual Meeting, April 8-13 in New Orleans. The session can be viewed on the virtual platform by registered meeting participants through July 13, 2022. Registration can be done here. Over 19,000 scientists and physicians are registered for this premier cancer conference, with ~80% (~15,200) attending in person and ~20% (~3,800) attending virtually. The AACR has over 50,000 members worldwide.
Login Or Register To Read Full Story